Genetics of Parkinson's disease: the yield
- PMID: 24262184
- DOI: 10.1016/S1353-8020(13)70011-7
Genetics of Parkinson's disease: the yield
Abstract
The discovery of genes implicated in familial forms of Parkinson's disease (PD) has provided new insights into the molecular events leading to neurodegeneration. Clinically, patients with genetically determined PD can be difficult to distinguish from those with sporadic PD. Monogenic causes include autosomal dominantly (SNCA, LRRK2, VPS35, EIF4G1) as well as recessively (PARK2, PINK1, DJ-1) inherited mutations. Additional recessive forms of parkinsonism present with atypical signs, including very early disease onset, dystonia, dementia and pyramidal signs. New techniques in the search for phenotype-associated genes (next-generation sequencing, genome-wide association studies) have expanded the spectrum of both monogenic PD and variants that alter risk to develop PD. Examples of risk genes include the two lysosomal enzyme coding genes GBA and SMPD1, which are associated with a 5-fold and 9-fold increased risk of PD, respectively. It is hoped that further knowledge of the genetic makeup of PD will allow designing treatments that alter the course of the disease.
Keywords: Molecular mechanisms; Monogenic forms; Parkinson; Risk genes.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Genetics of Parkinson's disease--state of the art, 2013.Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S23-8. doi: 10.1016/S1353-8020(13)70009-9. Parkinsonism Relat Disord. 2014. PMID: 24262182 Review.
-
Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations.Parkinsonism Relat Disord. 2013 Apr;19(4):407-15. doi: 10.1016/j.parkreldis.2013.01.020. Epub 2013 Feb 23. Parkinsonism Relat Disord. 2013. PMID: 23462481 Review.
-
Genetics of Parkinson's disease.Semin Neurol. 2011 Nov;31(5):433-40. doi: 10.1055/s-0031-1299782. Epub 2012 Jan 21. Semin Neurol. 2011. PMID: 22266881 Review.
-
The genetic landscape of Parkinson's disease.Rev Neurol (Paris). 2018 Nov;174(9):628-643. doi: 10.1016/j.neurol.2018.08.004. Epub 2018 Sep 21. Rev Neurol (Paris). 2018. PMID: 30245141 Review.
-
Parkinson's disease: from monogenic forms to genetic susceptibility factors.Hum Mol Genet. 2009 Apr 15;18(R1):R48-59. doi: 10.1093/hmg/ddp012. Hum Mol Genet. 2009. PMID: 19297401 Review.
Cited by
-
'Fly-ing' from rare to common neurodegenerative disease mechanisms.Trends Genet. 2022 Sep;38(9):972-984. doi: 10.1016/j.tig.2022.03.018. Epub 2022 Apr 25. Trends Genet. 2022. PMID: 35484057 Free PMC article. Review.
-
Neurotoxins as Preclinical Models for Parkinson's Disease.Neurotox Res. 2018 Nov;34(4):870-877. doi: 10.1007/s12640-017-9856-0. Epub 2018 Jan 8. Neurotox Res. 2018. PMID: 29313219 Review.
-
Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?Parkinsons Dis. 2015;2015:108029. doi: 10.1155/2015/108029. Epub 2015 Mar 31. Parkinsons Dis. 2015. PMID: 25918668 Free PMC article. Review.
-
Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.Int J Mol Sci. 2020 May 14;21(10):3459. doi: 10.3390/ijms21103459. Int J Mol Sci. 2020. PMID: 32422916 Free PMC article.
-
Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease.Neurobiol Dis. 2021 Apr;151:105267. doi: 10.1016/j.nbd.2021.105267. Epub 2021 Jan 12. Neurobiol Dis. 2021. PMID: 33450392 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous